Literature DB >> 7504287

Ribozyme cleaves rex/tax mRNA and inhibits bovine leukemia virus expression.

G H Cantor1, T F McElwain, T A Birkebak, G H Palmer.   

Abstract

Bovine leukemia virus (BLV) encodes at least two regulatory proteins, Rex and Tax. Tax, the transactivating protein, stimulates the long terminal repeat to promote viral transcription and may be involved in tumorigenesis. Rex is involved in the transition from early expression of regulatory proteins to later expression of viral structural proteins. We have targeted ribozymes against the mRNA encoding Rex and Tax. The ribozymes consist of the hammer-head catalytic motif flanked by antisense sequences that hybridize with the complementary rex/tax mRNA. To evaluate cleavage in a cell-free system, we transcribed portions of rex/tax mRNA and incubated them with synthetic RNA ribozymes. A ribozyme was identified that cleaves > 80% of the target RNA. Synthetic DNA encoding this ribozyme was cloned into the expression vector pRc/RSV and transfected into BLV-infected bat lung cells. Intracellular cleavage of rex/tax mRNA was confirmed by reverse transcriptase PCR. In cells expressing the ribozyme, viral expression was markedly inhibited. Expression of the BLV core protein p24 was inhibited by 61%, and reverse transcriptase activity in supernatant was inhibited by 92%. Ribozyme inhibition of BLV expression suggests that cattle expressing these sequences may be able to control BLV replication.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7504287      PMCID: PMC47895          DOI: 10.1073/pnas.90.23.10932

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Inhibition of bovine leukaemia virus replication by the antisense RNA in cell line CC81.

Authors:  A Borisenko; O Miroschnickhenko; T I Tikchonenko
Journal:  Virus Res       Date:  1992-04       Impact factor: 3.303

2.  Inhibition of Moloney murine leukemia virus-induced leukemia in transgenic mice expressing antisense RNA complementary to the retroviral packaging sequences.

Authors:  L Han; J S Yun; T E Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

3.  An improvement of the single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  C Puissant; L M Houdebine
Journal:  Biotechniques       Date:  1990-02       Impact factor: 1.993

Review 4.  Relationship between lymphosarcoma and persistent lymphocytosis in cattle: a review.

Authors:  J F Ferrer; R R Marshak; D A Abt; S J Kenyon
Journal:  J Am Vet Med Assoc       Date:  1979-10-01       Impact factor: 1.936

Review 5.  Modulation of eukaryotic gene expression by complementary RNA or DNA sequences.

Authors:  A R van der Krol; J N Mol; A R Stuitje
Journal:  Biotechniques       Date:  1988 Nov-Dec       Impact factor: 1.993

6.  Complete nucleotide sequence of the genome of bovine leukemia virus: its evolutionary relationship to other retroviruses.

Authors:  N Sagata; T Yasunaga; J Tsuzuku-Kawamura; K Ohishi; Y Ogawa; Y Ikawa
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

7.  Use of polymerase chain reaction to diagnose bovine leukemia virus infection in calves at birth.

Authors:  A Agresti; W Ponti; M Rocchi; R Meneveri; A Marozzi; D Cavalleri; E Peri; G Poli; E Ginelli
Journal:  Am J Vet Res       Date:  1993-03       Impact factor: 1.156

8.  trans-acting regulation of bovine leukemia virus mRNA processing.

Authors:  D Derse
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

9.  Infectivity in sheep of blood lymphocytes from bovine leukemia virus-infected cows with different nuclear pocket prevalences.

Authors:  A F Weber; M J Schmerr; D K Sorensen; C Bingham; K Pomeroy; J M Miller; M J Van Der Maaten
Journal:  Am J Vet Res       Date:  1983-10       Impact factor: 1.156

10.  Bovine leukemia virus trans-activator p38tax activates heterologous promoters with a common sequence known as a cAMP-responsive element or the binding site of a cellular transcription factor ATF.

Authors:  I Katoh; Y Yoshinaka; Y Ikawa
Journal:  EMBO J       Date:  1989-02       Impact factor: 11.598

View more
  21 in total

1.  C-SPACE (cleavage-specific amplification of cDNA ends): a novel method of ribozyme-mediated gene identification.

Authors:  M Krüger; C Beger; P J Welch; J R Barber; F Wong-Staal
Journal:  Nucleic Acids Res       Date:  2001-10-01       Impact factor: 16.971

2.  Efficient and specific ribozyme-mediated reduction of bovine alpha-lactalbumin expression in double transgenic mice.

Authors:  P J L'Huillier; S Soulier; M G Stinnakre; L Lepourry; S R Davis; J C Mercier; J L Vilotte
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

3.  Selection of efficient cleavage sites in target RNAs by using a ribozyme expression library.

Authors:  A Lieber; M Strauss
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

Review 4.  Antiviral therapy for human immunodeficiency virus infections.

Authors:  E De Clercq
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

Review 5.  Antigene, ribozyme and aptamer nucleic acid drugs: progress and prospects.

Authors:  R A Stull; F C Szoka
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

6.  Effective ribozyme delivery in plant cells.

Authors:  R Perriman; G Bruening; E S Dennis; W J Peacock
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

7.  "Hairpin" and "hammerhead" ribozymes directed towards the mumps virus nucleocapsid RNA: specific cleavage of a small synthetic RNA substrate and full-length mRNA.

Authors:  J Albuquerque-Silva; M J De Vos; A Bollen; S Houard
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

8.  A ribozyme specifically suppresses transformation and tumorigenicity of Ha-ras-oncogene-transformed NIH/3T3 cell lines.

Authors:  M Y Chang; S J Won; H S Liu
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

Review 9.  Antiviral ribozymes. New jobs for ancient molecules.

Authors:  A Menke; G Hobom
Journal:  Mol Biotechnol       Date:  1997-08       Impact factor: 2.695

10.  Strategies for the suppression of peroxidase gene expression in tobacco. I. Designing efficient ribozymes.

Authors:  C L McIntyre; J M Manners
Journal:  Transgenic Res       Date:  1996-07       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.